Senior Bioengineer, Vienna

Parallel Bio · Vienna

Apply on the company website

The Mission

Drug discovery has a translation problem: more than 95% of drugs that succeed in animal models fail in humans. We're building the alternative: human-first drug discovery, powered by organoids and AI, running on real human biology from the very first experiment.

Our platform is 87% concordant with clinical patient data - a vast improvement over the 3% translational success rate of animals. We’ve demonstrated the ability to model immunotoxicology, immunogen stimulation, and two autoimmune diseases with more on the way. Numerous pharma partners including 3 Fortune 500 companies are already using the platform. We've raised ~$30M from AIX Ventures, Marc Benioff, Jeff Dean, and Y Combinator. With the FDA Modernization Act 3.0 and the FDA's March 2026 validation framework, the regulatory tailwinds only continue to get stronger.

The opportunity ahead of the company is generational: build the first scaled engine for generating real human biological data, and use it to fundamentally change how medicines are discovered.

The Role

Note to candidates: the list below describes a strong profile, not a set of hard requirements. If you do not match every point but believe you are a strong candidate, please apply.

Our platform runs high-throughput immune organoid experiments to accelerate the development of new therapeutics. Building the next generation of models means building the culture formats they run in: the architecture of the construct, the hardware that holds it, and how separate compartments are brought into contact.

There is no established answer to any of that. The approach will be arrived at through successive prototypes rather than selected off the shelf, and setting the technical direction and the standard for what a finished format looks like is part of the role.

The work is done in close partnership with the assay development and platform teams across sites, so that what is built at the bench holds up when it becomes a process running at throughput. Breadth of immunological background matters more here than depth in any single indication, since the work will span disease areas as the platform develops.

The high-level goals for this role are fourfold:

  1. Advance the architecture and performance of our organoid models, including new approaches to integrating immune cells into tissue constructs.

  2. Design the physical formats that multi-organoid systems will need, including plate architecture, how organoids are nested, and whether and how they are allowed to interact.

  3. Develop co-culture systems that combine immune organoids with other tissues to support disease modeling across multiple indications.

  4. Bring bench-level automation into routine culture work, from custom culture hardware through to automated media handling.

This is a hands-on role with a high degree of independence at the bench. The project is one to own end to end: designing and building the solutions, making the technical calls that move the work forward, and running several workstreams in parallel. The role works closely with automation and software teams across sites.

Note that maintaining cell cultures and experimental continuity requires some weekend work on a rotating basis.

Areas of Responsibility

Organoid engineering

Multi-organoid and multi-tissue formats

Transfer and automation

Team and culture

Job Requirements

Technical abilities

Independence and problem-solving

Parallel Bio is an equal opportunity employer committed to fostering an inclusive and respectful workplace. We encourage applications from individuals of all backgrounds, regardless of age, gender, ethnicity, religion, disability, or sexual orientation.

More jobs at Parallel Bio · Other jobs in Vienna